Team Hewins »

Regeneron Pharmaceuticals shares owned by Team Hewins

Quarter-by-quarter ownership of Regeneron Pharmaceuticals (REGN) shares owned by Team Hewins from 13F filings

Historical chart of Team Hewins investment in Regeneron Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Regeneron Pharmaceuticals held by Team Hewins consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Regeneron Pharmaceuticals by Team Hewins

Quarter filed Position value Share count Share price at filing
2024-03-31 $434k 451 962.49
2023-12-31 $386k 440 878.29

More positions owned by Team Hewins

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Dimensional Etf Trust Internatnal Val (DFIV)
Dimensional Etf Trust Us Targeted Vlu (DFAT)
Dimensional Etf Trust Us Mktwide Value (DFUV)
Ishares Tr Msci Eafe Etf (EFA)
American Centy Etf Tr Us Sml Cp Valu (AVUV)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Dimensional Etf Trust Us Large Cap Val (DFLV)
Apple (AAPL)
Meta Platforms Cl A (META)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Ishares Tr Msci Emg Mkt Etf (EEM)
American Centy Etf Tr Avantis Emgmkt (AVEM)

View all positions for Team Hewins

Top funds holding Regeneron Pharmaceuticals

FMR
Vanguard Group
BlackRock
Jpmorgan Chase & Co
Geode Capital Management
Dodge & Cox
Franklin Resources
Morgan Stanley
Loomis, Sayles and
Wellington Management Company
Amundi
Northern Trust
Legal & General Group
Bank of America Corporation
T. Rowe Price Associates

View all funds holding Regeneron Pharmaceuticals